1
|
Oyarzun-Domeño A, Cia I, Echeverria-Chasco R, Fernández-Seara MA, Martin-Moreno PL, Garcia-Fernandez N, Bastarrika G, Navallas J, Villanueva A. A deep learning image analysis method for renal perfusion estimation in pseudo-continuous arterial spin labelling MRI. Magn Reson Imaging 2023; 104:39-51. [PMID: 37776961 DOI: 10.1016/j.mri.2023.09.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Revised: 08/10/2023] [Accepted: 09/25/2023] [Indexed: 10/02/2023]
Abstract
Accurate segmentation of renal tissues is an essential step for renal perfusion estimation and postoperative assessment of the allograft. Images are usually manually labeled, which is tedious and prone to human error. We present an image analysis method for the automatic estimation of renal perfusion based on perfusion magnetic resonance imaging. Specifically, non-contrasted pseudo-continuous arterial spin labeling (PCASL) images are used for kidney transplant evaluation and perfusion estimation, as a biomarker of the status of the allograft. The proposed method uses machine/deep learning tools for the segmentation and classification of renal cortical and medullary tissues and automates the estimation of perfusion values. Data from 16 transplant patients has been used for the experiments. The automatic analysis of differentiated tissues within the kidney, such as cortex and medulla, is performed by employing the time-intensity-curves of non-contrasted T1-weighted MRI series. Specifically, using the Dice similarity coefficient as a figure of merit, results above 93%, 92% and 82% are obtained for whole kidney, cortex, and medulla, respectively. Besides, estimated cortical and medullary perfusion values are considered to be within the acceptable ranges within clinical practice.
Collapse
Affiliation(s)
- Anne Oyarzun-Domeño
- Electrical Electronics and Communications Engineering, Public University of Navarre, 31006 Pamplona, Spain; IdiSNA, Health Research Institute of Navarra, 31008, Spain.
| | - Izaskun Cia
- Electrical Electronics and Communications Engineering, Public University of Navarre, 31006 Pamplona, Spain.
| | - Rebeca Echeverria-Chasco
- IdiSNA, Health Research Institute of Navarra, 31008, Spain; Department of Radiology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
| | - María A Fernández-Seara
- IdiSNA, Health Research Institute of Navarra, 31008, Spain; Department of Radiology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
| | - Paloma L Martin-Moreno
- IdiSNA, Health Research Institute of Navarra, 31008, Spain; Department of Nephrology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
| | - Nuria Garcia-Fernandez
- IdiSNA, Health Research Institute of Navarra, 31008, Spain; Department of Nephrology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
| | - Gorka Bastarrika
- IdiSNA, Health Research Institute of Navarra, 31008, Spain; Department of Radiology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
| | - Javier Navallas
- Electrical Electronics and Communications Engineering, Public University of Navarre, 31006 Pamplona, Spain; IdiSNA, Health Research Institute of Navarra, 31008, Spain.
| | - Arantxa Villanueva
- Electrical Electronics and Communications Engineering, Public University of Navarre, 31006 Pamplona, Spain; IdiSNA, Health Research Institute of Navarra, 31008, Spain; Institute of Smart Cities (ISC), Health Research Institute of Navarra, 31006, Pamplona, Spain.
| |
Collapse
|
2
|
Puchulu MB, Garcia-Fernandez N, Landry MJ. Food Insecurity and Chronic Kidney Disease: Considerations for Practitioners. J Ren Nutr 2023; 33:691-697. [PMID: 37331455 PMCID: PMC10275650 DOI: 10.1053/j.jrn.2023.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2022] [Revised: 04/18/2023] [Accepted: 06/04/2023] [Indexed: 06/20/2023] Open
Abstract
The coronavirus disease 2019 pandemic has exacerbated existing health disparities related to food security status. Emerging literature suggests individuals with Chronic Kidney Disease (CKD) who are also food insecure have a greater likelihood of disease progression compared to food secure individuals. However, the complex relationship between CKD and food insecurity (FI) is understudied relative to other chronic conditions. The purpose of this practical application article is to summarize the recent literature on the social-economic, nutritional, to care through which FI may negatively impact health outcomes in individuals with CKD. While several studies have reported on the cross-sectional prevalence of FI among persons with CKD, literature is lacking about the severity and duration of exposure to FI on CKD outcomes. Future research is needed to better understand how FI impairs CKD care, nutritional and structural barriers that impact disease prevention and disease progression, and effective strategies to support patients.
Collapse
Affiliation(s)
- María B Puchulu
- Departamento de Ciencias Fisiológicas, Universidad de Buenos Aires, Facultad de Medicina, Buenos Aires, Argentina.
| | - Nuria Garcia-Fernandez
- Nephrology Department, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de, Navarra (IdiSNA), Pamplona, Spain
| | - Matthew J Landry
- Department of Medicine, Stanford Prevention Research Center, School of Medicine, Stanford University, Stanford, California
| |
Collapse
|
3
|
Abasheva D, Dolcet-Negre MM, Fernández-Seara MA, Mora-Gutiérrez JM, Orbe J, Escalada FJ, Garcia-Fernandez N. Association between Circulating Levels of 25-Hydroxyvitamin D 3 and Matrix Metalloproteinase-10 (MMP-10) in Patients with Type 2 Diabetes. Nutrients 2022; 14:nu14173484. [PMID: 36079742 PMCID: PMC9458174 DOI: 10.3390/nu14173484] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 08/18/2022] [Accepted: 08/19/2022] [Indexed: 12/01/2022] Open
Abstract
Background: Matrix metalloproteinase-10 (MMP-10) levels increase progressively starting from early diabetic kidney disease (DKD) stages. Vitamin D3 (vitD3) deficit is associated with a higher risk of diabetic microangiopathy. Reduced MMP-10 expression has been observed after exposure to vitD3. Aim: to assess how vitD3 status is related to MMP-10 levels in patients with Type 2 diabetes (T2D). Methods: 256 patients with T2D were included in this cross-sectional study. Demographic, clinical and serum MMP-10 and 25-hydroxyvitamin D3 (25(OH)D3) levels were collected from each patient. The association between MMP-10 and (25(OH)D3) levels was assessed using a correlation analysis and fitting a multivariate linear regression model. Results: Serum MMP-10 levels were inversely correlated with circulating 25(OH)D3 (rho = −0.25; p < 0.001). In the subgroup analysis this correlation was significant in patients with DKD (rho = −0.28; p = 0.001) and in subjects with vitD3 deficit (rho = −0.24; p = 0.005). In the regression model adjusted for kidney function, body adiposity, smoking and vitD supplementation MMP-10 levels were 68.7 pg/mL lower in patients with 25(OH)D3 > 20 ng/mL, with respect to ≤20 ng/mL (p = 0.006). Conclusions: vitD3 repletion status is an independent predictor of MMP-10 levels in T2D patients. Perhaps, high 25(OH)D3 values should be targeted in these patients in order to prevent vascular complications.
Collapse
Affiliation(s)
- Daria Abasheva
- School of Medicine, University of Navarra, 31009 Pamplona, Spain
| | | | - María A. Fernández-Seara
- Radiology Department, Clínica Universidad de Navarra, 31008 Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain
| | | | - Josune Orbe
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain
- Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA, University of Navarra, 31008 Pamplona, Spain
- RICORS-Cerebrovascular Diseases, Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Francisco Javier Escalada
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain
- Endocrinology and Nutrition Department, Clínica Universidad de Navarra, 31008 Pamplona, Spain
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Nuria Garcia-Fernandez
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain
- Nephrology Department, Clínica Universidad de Navarra, 31008 Pamplona, Spain
- Red de Investigación Renal (REDINREN) and RICORS2040, Instituto de Salud Carlos III, 28029 Madrid, Spain
- Correspondence: ; Tel.: +34-948255400
| |
Collapse
|
4
|
Quiroga B, Soler MJ, Ortiz A, Mantecón CJJ, Pérez NN, Martín MS, Sato Y, Franco AJM, Zambrano DFP, Valverde RL, Diaz MO, González CC, López JMC, Pereira M, Parra EG, Horrillo AS, González CS, Toapanta N, Guldris SC, Hernández RS, Sánchez SP, Rincón MM, Garcia-Fernandez N, Castro NB, Mateo RC, Morales MAQ, Escamilla-Cabrera B, Godoy IB, Casanova BGC, Leyva A, Rojas J, Gansevoort RT, de Sequera P, Carretero MP, Tocora DG, Rodríguez MTJ, Zanón TT, Suárez ER, Santolaya AJS, Calero RC, Cobo PA, Ramos PM, Gracia-Iguacel C, Martin-Cleary C, Sánchez-Rodríguez J, Ramos-Verde A, Giraldo YG, Suárez PR, Perpén AF, Ramos AF, Villanueva LS, Cortiñas A, Arias PAD, Cárdenas AC, de Santos A, Núñez A, Cuadrado GB, Repollet R, Moreso F, Azancot MA, Ramos N, Bestard O, Cidraque I, Bermejo S, Agraz I, Prat O, Medina C, Pardo E, Saiz A, Granados NM, Cabo MJC, Alarcón WL, Alexandru S, Suarez LGP, Saico SP, Tapia MP, Osorio LR, Zamora R, Moreno PLM, González NA, Ortiz AS, Iñarrea MNB, García T, Narváez C, Orellana C, León JLP, García MAM, Jiménez BG, Moya JDDR, Espinosa DL, Herrador AJ, Zurita MN, Díaz Álvarez L, Martínez ÁG, Arroyo SB, Fernández RR, Vargas MJS, Casero RC, Useche G, de Miguel CS, Palacios Á, Henningsmeyer B, Calve EO, Moya JL, Gash SC, Martínez LR, Perez VLDLM, Arevalo MC, Calvo JAH, Salgueira M, Aresté N, Rodríguez MDLÁ, Collantes R, Martínez AI, Moyano MJ, Víbora EJ, Hernández APR, Rebollo MSG, Hernández JMR, Aguilera ET, Alea RT, Saldaña MSDR, de la Pisa AMU, Monzon LS, Anachuri KA, Garcia EH, Gomez VO, Cavalotti IM, Zorita IN, López SO, González SO, Montañez CS, Serna MRDA, Perich LG, de la Rosa EC. Anti-Spike antibodies three months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study. Clin Kidney J 2022; 15:1856-1864. [PMID: 36147708 PMCID: PMC9384616 DOI: 10.1093/ckj/sfac169] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Patients on hemodialysis are at high-risk for complications derived from coronavirus disease-19 (COVID-19). The present analysis evaluated the impact of a booster vaccine dose and breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on humoral immunity three months after the booster dose.
Methods
This is a multicentric and prospective study assessing IgG anti-Spike antibodies 6 and 9 months after initial SARS-CoV-2 vaccination in patients on hemodialysis that had also received a booster dose before the 6-month assessment (early booster) or between the 6- and 9-month assessments (late booster). The impact of breakthrough infections, type of vaccine, time from the booster and clinical variables were assessed.
Results
A total of 711 patients (67% male, 67 [20-89] years) were included. Of which, 545 (77%) received an early booster and the rest a late booster. At 6 months, 64 (9%) patients had negative anti-Spike antibody titers (3% of early booster and 29% of late booster patients, p = 0.001). At 9 months, 91% of patients with 6-month negative response had seroconverted and there were no differences in residual prevalence of negative humoral response between early and late booster patients (0.9% vs 0.6%, p = 0.693). During follow-up, 35 patients (5%) developed breakthrough SARS-CoV-2 infection. Antibody titers at 9 months were independently associated to mRNA-1273 booster (p = 0.001), lower time from booster (p = 0.043) and past breakthrough SARS-CoV-2 infection (p<0.001).
Conclusions
In hemodialysis patients, higher titers of anti-Spike antibodies at 9 months were associated to mRNA-1273 booster, lower time from booster and past breakthrough SARS-CoV-2 infection.
Collapse
Affiliation(s)
- Borja Quiroga
- IIS-La Princesa. Nephrology Department, Hospital Universitario de la Princesa , Madrid ( Spain )
| | - María José Soler
- Nephrology Department, Vall d'Hebrón University Hospital , 08035 Barcelona ( Spain )
- RICORS2040 (Kidney Disease)
| | - Alberto Ortiz
- RICORS2040 (Kidney Disease)
- IIS-Fundación Jiménez Diaz, School of Medicine, Universidad Autónoma de Madrid, Fundación Renal Iñigo Álvarez de Toledo-IRSIN, REDinREN, Instituto de Investigación Carlos III , Madrid ( Spain )
| | | | | | | | | | | | | | - Rafael Lucena Valverde
- Nephrology Department, Hospital Universitario Infanta Leonor – Universidad Complutense de Madrid ( Spain )
| | - Mayra Ortega Diaz
- Nephrology Department, Hospital Universitario Infanta Leonor – Universidad Complutense de Madrid ( Spain )
| | | | | | - Mónica Pereira
- IIS-Fundación Jiménez Diaz, School of Medicine, Universidad Autónoma de Madrid, Fundación Renal Iñigo Álvarez de Toledo-IRSIN, REDinREN, Instituto de Investigación Carlos III , Madrid ( Spain )
| | - Emilio González Parra
- IIS-Fundación Jiménez Diaz, School of Medicine, Universidad Autónoma de Madrid, Fundación Renal Iñigo Álvarez de Toledo-IRSIN, REDinREN, Instituto de Investigación Carlos III , Madrid ( Spain )
| | - Ana Sánchez Horrillo
- IIS-La Princesa. Nephrology Department, Hospital Universitario de la Princesa , Madrid ( Spain )
| | - Carmen Sánchez González
- IIS-La Princesa. Nephrology Department, Hospital Universitario de la Princesa , Madrid ( Spain )
| | - Néstor Toapanta
- Nephrology Department, Vall d'Hebrón University Hospital , 08035 Barcelona ( Spain )
| | | | | | | | | | | | | | | | | | | | | | | | - Alba Leyva
- R&D Department , VIRCELL SL, Granada ( Spain )
| | - José Rojas
- R&D Department , VIRCELL SL, Granada ( Spain )
| | - Ron T Gansevoort
- Dept. Internal Medicine, University Medical Center Groningen, University of Groningen , Groningen , The Netherlands
| | - Patricia de Sequera
- RICORS2040 (Kidney Disease)
- Nephrology Department, Hospital Universitario Infanta Leonor – Universidad Complutense de Madrid ( Spain )
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Abasheva D, Marta D, Fernandez-Seara MA, Maria Mora Gutierrez J, Antonio Rodriguez J, Javier Escalada F, Orbe J, Garcia-Fernandez N. FC 126: Association Between Circulating Levels of 25-Hydroxyvitamin D and Metalloproteinase-10 (MMP 10) in Patients With Type 2 Diabetes Mellitus. Cross-Sectional Study. Nephrol Dial Transplant 2022. [DOI: 10.1093/ndt/gfac126.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
BACKGROUND AND AIMS
Matrix metalloproteinases (MMP) play an important role in diabetic kidney disease (DKD) (1). MMP-10 levels have been shown to increase progressively starting from the early stages of DKD (2). Vitamin D (vitD) deficit is associated with a higher risk of microangiopathy in diabetes. In humans, vitD status correlates inversely with MMP-9 circulating levels and VitD supplementation is associated with a decrease in these levels (3). In vitro, studies demonstrated reduced expression of MMP-10 after an exposure to vitD (4). However, no studies have yet assessed how vitD status is related to MMP-10 circulating levels. We aimed (1) to evaluate the association between the serum levels of 25-hydroxyvitamin D [25(OH)D3] and MMP-10 in a cohort of type 2 diabetes (T2D) patients and (2) to study a potential effect of chronic kidney disease (CKD) stage or estimated glomerular filtration rate (eGFRcr) on this association.
METHOD
The cross-sectional association between MMP-10 and 25(OH)D3 levels (>30 ng/mL, normal; 20–30 ng/mL, insufficiency; <20 ng/mL, deficiency; and relevant cut-offs 45 and 15 ng/mL) was investigated, by multivariate linear regression analysis after MMP-10 logarithm transformation, in 256 T2D patients recruited (2009–2016) in the Clinica Universidad de Navarra (Spain). Study protocol was approved by the Ethical Committee (2021.183TFG). Covariates were smoking habit, body adiposity percentage estimated by CUN-BAE formula, CKD stage and vitD3 supplement use. Age and sex were already included in the CKD-EPI formula. Interactions and collinearities were also analysed. Statistical analysis was performed using STATA software and two-tailed P-values <0.05 were considered statistically significant.
RESULTS
Characteristics of patients are given in Table 1. VitD deficit was significantly (P <0.001) more prevalent in patients with CKD (61%) compared with those without CKD (40%). MMP-10 showed a significant negative correlation with 25(OH)D3 (rho = –0.246; P <0.001), which remained significant including only CKD patients (rho = –0.283; P <0.001) and stronger above 45 ng/mL (rho = –0.7308, P <0.001) or moderate between 30 and 45 ng/mL (rho = –0.3290, P = 0.0045) (Fig. 1). In the fully adjusted model, MMP-10 was negatively associated (P = 0.019) with severe vitD deficiency [estimated coefficient –0.86 (–0.76 to –0.97)]. There was no interaction between covariates and 25(OH)D levels and collinearities were also discarded.
CONCLUSION
In T2D patients, circulating MMP-10 was inversely associated with serum 25(OH)D3 levels, especially in those patients with CKD and at the extremes of vitD level range. These results suggest that higher values of 25(OH)D3 should be targeted in these patients. The efficacy of vitD supplementation in reducing circulating MMP-10 levels should be further examined.
Collapse
Affiliation(s)
- Daria Abasheva
- School of Medicine, University of Navarra, Pamplona, Spain
| | - Dolcet Marta
- Radiology, Clinica Universidad de Navarra, Pamplona, Spain
| | | | | | - Jose Antonio Rodriguez
- Centro de Investigacion medica Aplicada (CIMA), University of Navarra, Atherotrombosis, Cardiovascular Disease Program, Pamplona, Spain
| | | | - Josune Orbe
- Centro de Investigacion medica Aplicada (CIMA), University of Navarra, Atherotrombosis, Cardiovascular Disease Program, Pamplona, Spain
| | | |
Collapse
|
6
|
Romero-González G, Ravassa S, Diaz-Dorronsoro A, De la Fuente A, Garcia-Fernandez N, Rojas MA, Lorenzo I, García-Trigo I, Mateo-De Castro FM, López B, González A, Diez J. MO734CONTRIBUTION OF SOLUBLE ST2 TO THE EFFECT OF RIGHT VENTRICULAR DYSFUNCTION ON MORTALITY IN HEMODIALYSIS PATIENTS. Nephrol Dial Transplant 2021. [DOI: 10.1093/ndt/gfab097.0014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background and Aims
Right ventricular dysfunction (RVD) has been shown to predict mortality in patients with kidney failure. It has been proposed that RVD in these patients is mediated by inflammatory and fibrotic mechanisms, which may be enhanced by hemodialysis (HD). The present study aimed to investigate the potential associations between RVD and circulating biomarkers of myocardial inflammation and fibrosis with all-cause mortality in HD patients.
Method
We performed a retrospective single-centre cohort study of prevalent patients admitted in a chronic HD program for more than 3 months. Clinical characteristics and echocardiographic parameters were assessed in all patients. Pre-dialysis blood samples for measurement of inflammatory (e.g., C reactive protein, interleukin-1, interleukin-18) and fibrotic (e.g., soluble suppression of tumorigenesis-2 [sST2], galectin-3, C-terminal pro-peptide of procollagen type I and N-terminal pro-peptide of procollagen type III) biomarkers were collected. Right ventricular dysfunction (RVD) was defined using tricuspid annular plane systolic excursion (TAPSE) <1.7 cm or pulsed Doppler peak annular velocity (S´) <9.5 cm/s. The ability of sST2 to discriminate between mortality was assessed using AuROC curve.
Results
We enrolled 48 patients (mean age 74 [64–79] years, 62.5% males) followed over a period of 1.4 years. Mortality was higher 45.5% (log-rank, p=0.003) in patients with RVD as diagnosed by S' than in patients without RVD. No difference in mortality was observed for RVD defined by TAPSE. There were no differences in the morphology and function parameters of the left ventricle between patients with and without RVD. From all biomarkers measured only sST2 was associated with RVD. Indeed, an age- and sex-adjusted analyses showed that doubling of sST2 was inversely associated with a decreased in S´ (estimate=-2.03, 95% CI [-3.04 to -1.00] cm/s; P=0.002). Mortality was increased in patients with sST2 ≥40.45 ng/mL compared to patients with sST2 <40.45 ng/mL (66.7% vs. 18.9%, log-rank; p=0.004). Crude analysis showed that patients presenting with S’ <9.5 cm/s and sST2 ≥40.45 ng/mL exhibited higher mortality (log-rank; p=0.001) than patients with S’ >9.5 cm/s and sST2 <40.45pg/mL.
Conclusion
Albeit preliminary these findings suggest that an excess of sST2 may be involved in RVD and on its effect on mortality in HD patients. The myocardial pro-remodeling effect of sST2 among HD patients with RVD warrants further investigation.
Collapse
Affiliation(s)
- Gregorio Romero-González
- Complejo Hospitalario de Navarra, Nephrology, Pamplona, Spain
- Centre for Applied Medical Research - University of Navarra, Program of Cardiovascular Disease, Pamplona, Spain
| | - Susanna Ravassa
- Centre for Applied Medical Research - University of Navarra, Program of Cardiovascular Disease, Pamplona, Spain
| | | | | | | | - Miguel A Rojas
- Clinica Universidad de Navarra, Nephrology, Pamplona, Spain
| | | | | | | | - Begoña López
- Centre for Applied Medical Research - University of Navarra, Program of Cardiovascular Disease, Pamplona, Spain
| | - Arantxa González
- Centre for Applied Medical Research - University of Navarra, Program of Cardiovascular Disease, Pamplona, Spain
| | - Javier Diez
- Centre for Applied Medical Research - University of Navarra, Program of Cardiovascular Disease, Pamplona, Spain
- Clinica Universidad de Navarra, Cardiology, Pamplona, Spain
- Clinica Universidad de Navarra, Nephrology, Pamplona, Spain
| |
Collapse
|
7
|
Garcia-Fernandez N, Hassan A, Anand S. Effect of exopolysaccharides produced by dairy starter cultures on biofilms formed on reverse osmosis membranes. JDS Communications 2021; 2:104-109. [PMID: 36339503 PMCID: PMC9623752 DOI: 10.3168/jdsc.2020-0041] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/20/2020] [Accepted: 01/19/2021] [Indexed: 11/19/2022]
Abstract
Not all EPS-producing starter cultures have an advantage in regard to their ability to form biofilm on membrane separation surfaces. Variations between different EPS modify adhesive behavior to reverse osmosis membranes. Cell hydrophobicity is critical for initial adhesion to RO membrane separation surface and thus biofilm formation.
Two different cheese starter cultures producing exopolysaccharides (EPS+: Streptococcus thermophilus strain ST3534 and Lactococcus lactis ssp. cremoris strain JFR+) and their isogenic EPS-negative (EPS−: S. thermophilus strain ST5842 and L. lactis ssp. cremoris strain JFR–) variants were used to study the attachment of bacterial cells in the absence of growth (at 4°C) and the resultant biofilm formation on reverse osmosis membranes (at 30 or 35°C). We used M17 broth and a 10% solution of whey protein concentrate (with 35% protein) as growth media for biofilm development under static conditions. As expected, ST3534 (EPS+) showed significantly greater cell counts within biofilms than ST5842 (EPS−). In the absence of growth, however, cells of these 2 isogenic Streptococcus strains attached to the membrane in similar numbers. In contrast, JFR+ counts were significantly lower than those of JFR– under all conditions. These findings indicate that the EPS produced by S. thermophilus may play a greater role in building up the 3-dimensional structure of the biofilm, rather than only assisting during initial attachment of the cells to the membrane, whereas the EPS produced by L. lactis ssp. cremoris hampered both initial attachment to the membrane and biofilm formation. Although no differences were observed in the surface charge of the cells between the 2 EPS-producing cultures, surface hydrophobicity was associated with the different adhesive properties of these microorganisms. In conclusion, our results exclude the hypothesis that all EPS-producing starter cultures have an advantage in regard to their ability to form biofilm on membrane separation surfaces. In contrast, variations between different EPS, with hydrophobicity being an important influencing feature, modify adhesive behavior to reverse osmosis membranes.
Collapse
|
8
|
Kumar R, Register K, Christopher-Hennings J, Moroni P, Gioia G, Garcia-Fernandez N, Nelson J, Jelinski MD, Lysnyansky I, Bayles D, Alt D, Scaria J. Population Genomic Analysis of Mycoplasma bovis Elucidates Geographical Variations and Genes associated with Host-Types. Microorganisms 2020; 8:microorganisms8101561. [PMID: 33050495 PMCID: PMC7650767 DOI: 10.3390/microorganisms8101561] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Revised: 10/05/2020] [Accepted: 10/07/2020] [Indexed: 11/16/2022] Open
Abstract
Among more than twenty species belonging to the class Mollecutes, Mycoplasma bovis is the most common cause of bovine mycoplasmosis in North America and Europe. Bovine mycoplasmosis causes significant economic loss in the cattle industry. The number of M. bovis positive herds recently has increased in North America and Europe. Since antibiotic treatment is ineffective and no efficient vaccine is available, M. bovis induced mycoplasmosis is primarily controlled by herd management measures such as the restriction of moving infected animals out of the herds and culling of infected or shedders of M. bovis. To better understand the population structure and genomic factors that may contribute to its transmission, we sequenced 147 M. bovis strains isolated from four different countries viz. USA (n = 121), Canada (n = 22), Israel (n = 3) and Lithuania (n = 1). All except two of the isolates (KRB1 and KRB8) were isolated from two host types i.e., bovine (n = 75) and bison (n = 70). We performed a large-scale comparative analysis of M. bovis genomes by integrating 103 publicly available genomes and our dataset (250 total genomes). Whole genome single nucleotide polymorphism (SNP) based phylogeny using M.agalactiae as an outgroup revealed that M. bovis population structure is composed of five different clades. USA isolates showed a high degree of genomic divergence in comparison to the Australian isolates. Based on host of origin, all the isolates in clade IV was of bovine origin, whereas majority of the isolates in clades III and V was of bison origin. Our comparative genome analysis also revealed that M. bovis has an open pangenome with a large breadth of unexplored diversity of genes. The function based analysis of autogenous vaccine candidates (n = 10) included in this study revealed that their functional diversity does not span the genomic diversity observed in all five clades identified in this study. Our study also found that M. bovis genome harbors a large number of IS elements and their number increases significantly (p = 7.8 × 10−6) as the genome size increases. Collectively, the genome data and the whole genome-based population analysis in this study may help to develop better understanding of M. bovis induced mycoplasmosis in cattle.
Collapse
Affiliation(s)
- Roshan Kumar
- Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD 57007, USA; (R.K.); (J.C.-H.); (N.G.-F.); (J.N.)
- South Dakota Center for Biologics Research and Commercialization, Brookings, SD 57007, USA
- P.G. Department of Zoology, Magadh University, Bodh Gaya, Bihar 824234, India
| | - Karen Register
- USDA/ARS/National Animal Disease Center, Ruminant Diseases & Immunology Research Unit, Ames, IA 50010, USA;
| | - Jane Christopher-Hennings
- Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD 57007, USA; (R.K.); (J.C.-H.); (N.G.-F.); (J.N.)
- South Dakota Center for Biologics Research and Commercialization, Brookings, SD 57007, USA
| | - Paolo Moroni
- Quality Milk Production Services, Animal Health Diagnostic Center, Cornell University, 240 Farrier Road, Ithaca, NY 14850, USA; (P.M.); (G.G.)
- Dipartimento di Medicina Veterinaria, Via dell’Università, Università degli Studi di Milano, 6, 26900 Lodi LO, Italy
| | - Gloria Gioia
- Quality Milk Production Services, Animal Health Diagnostic Center, Cornell University, 240 Farrier Road, Ithaca, NY 14850, USA; (P.M.); (G.G.)
| | - Nuria Garcia-Fernandez
- Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD 57007, USA; (R.K.); (J.C.-H.); (N.G.-F.); (J.N.)
| | - Julia Nelson
- Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD 57007, USA; (R.K.); (J.C.-H.); (N.G.-F.); (J.N.)
- South Dakota Center for Biologics Research and Commercialization, Brookings, SD 57007, USA
| | - Murray D. Jelinski
- Department of Large Animal Clinical Sciences, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada;
| | - Inna Lysnyansky
- Division of Avian Diseases, Kimron Veterinary Institute, Beit Dagan 50250, Israel;
| | - Darrell Bayles
- USDA/ARS/National Animal Disease Center, Infectious Bacterial Diseases Research Unit, Ames, IA 50010, USA; (D.B.); (D.A.)
| | - David Alt
- USDA/ARS/National Animal Disease Center, Infectious Bacterial Diseases Research Unit, Ames, IA 50010, USA; (D.B.); (D.A.)
| | - Joy Scaria
- Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD 57007, USA; (R.K.); (J.C.-H.); (N.G.-F.); (J.N.)
- South Dakota Center for Biologics Research and Commercialization, Brookings, SD 57007, USA
- Correspondence:
| |
Collapse
|
9
|
Echeverria-Chasco R, Vidorreta M, Aramendía-Vidaurreta V, Cano D, Escalada J, Garcia-Fernandez N, Bastarrika G, Fernández-Seara MA. Optimization of pseudo-continuous arterial spin labeling for renal perfusion imaging. Magn Reson Med 2020; 85:1507-1521. [PMID: 33017483 DOI: 10.1002/mrm.28531] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Revised: 09/03/2020] [Accepted: 09/03/2020] [Indexed: 11/09/2022]
Abstract
PURPOSE To evaluate labeling efficiency of pseudo-continuous arterial spin labeling (PCASL) and to find the gradient parameters that increase PCASL robustness for renal perfusion measurements. METHODS Aortic blood flow was characterized in 3 groups: young healthy volunteers (YHV1), chronic kidney disease (CKD) patients (CKDP), and healthy controls (HCO). PCASL inversion efficiency was evaluated through numeric simulations considering the measured pulsatile flow velocity profiles and off-resonance effects for a wide range of gradient parameters, and the results were assessed in vivo. The most robust PCASL implementation was used to measure renal blood flow (RBF) in CKDP and HCO. RESULTS Aortic blood velocities reached peak values of 120 cm/s in YHV1, whereas for elderly subjects values were lower by approximately a factor of 2. Simulations and experiments showed that by reducing the gradient average (Gave ) and the selective to average gradient ratio (Gmax /Gave ), labeling efficiency was maximized and PCASL robustness to off-resonance was improved. The study in CKDP and HCO showed significant differences in RBF between groups. CONCLUSION An efficient and robust PCASL scheme for renal applications requires a Gmax /Gave ratio of 6-7 and a Gave value that depends on the aortic blood flow velocities (0.5 mT/m being appropriate for CKDP and HCO).
Collapse
Affiliation(s)
- Rebeca Echeverria-Chasco
- Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain.,IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
| | | | - Verónica Aramendía-Vidaurreta
- Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain.,IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
| | - David Cano
- Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain
| | - Javier Escalada
- Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain
| | - Nuria Garcia-Fernandez
- IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.,Department of Nephrology, Clínica Universidad de Navarra, Pamplona, Spain
| | - Gorka Bastarrika
- Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain.,IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
| | - María A Fernández-Seara
- Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain.,IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
| |
Collapse
|
10
|
Romero-González G, Diaz-Dorronsoro A, De la Fuente A, Ravassa S, Garcia-Fernandez N, Martin-Moreno PL, Lavilla J, González O, Rojas MA, Lorenzo I, García-Trigo I, Ania N, Osácar E, Sabalza A, Amézqueta P, López B, González A, Diez J. P1309RIGHT VENTRICULAR-PULMONARY ARTERIAL UNCOUPLING IN PATIENTS ON CHRONIC HEMODIALYSIS WITH SEVERE RIGHT VENTRICULAR REMODELING. Nephrol Dial Transplant 2020. [DOI: 10.1093/ndt/gfaa142.p1309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and Aims
Patients on chronic hemodialysis (HD) may present right ventricular (RV) dysfunction and increased pulmonary artery pressure (PA). The aim of the current study is to describe the RV-PA coupling in chronic patients on HD.
Method
This study explored the adequacy of RV-PA coupling in 41 patients on HD. They underwent a comprehensive transthoracic Doppler echocardiography, and were stratified in accordance with the severity of RV remodeling defined by the presence of RV dilation (tricuspid annulus ≥40 mm) and RV systolic dysfunction (tricuspid annulus systolic excursion plane [TAPSE] <17 mm). RV-PA coupling was estimated by the TAPSE to PA systolic pressure (TAPSE:PASP) ratio.
Results
Three groups of patients were identified: No RV remodeling (Group 1, n=26), mild-to-moderate RV remodeling (Group 2, n=11) and severe RV remodeling (Group 3, n=4). Compared to patients from Groups 1 and 2, patients from Group 3 exhibited significant lower TAPSE values (p<0.001), a tendency to higher PASP values (p=0.054) and significant lower TAPSE:PASP ratio values (p=0.012). C-reactive protein levels and were directly correlated with PASP (r=0.405, p=0.017) and inversely with TAPSE (r=-0.311, p=0.041) and the TAPSE:PASP ratio (r= -0.392, p=0.015) in all patients. These echocardiographic parameters were not correlated with other biochemical, hemodynamic or anthropometric parameters.
Conclusion
These findings suggest that RV-PA coupling is markedly decreased in HD patients with severe RV remodeling. The role of systemic inflammation in RV remodeling and RV-PA uncoupling in HD patients warrants further studies.
Collapse
Affiliation(s)
- Gregorio Romero-González
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
- CIMA (Center for Applied Medical Research) University of Navarre, Cardiovascular Disease, Pamplona, Spain
| | - Agnes Diaz-Dorronsoro
- CIMA (Center for Applied Medical Research) University of Navarre, Cardiovascular Disease, Pamplona, Spain
- University of Navarra Clinic, Cardiology Department, Pamplona, Spain
| | - Ana De la Fuente
- University of Navarra Clinic, Cardiology Department, Pamplona, Spain
| | - Susanna Ravassa
- CIMA (Center for Applied Medical Research) University of Navarre, Cardiovascular Disease, Pamplona, Spain
| | | | | | - Javier Lavilla
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
| | - Omar González
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
| | - Miguel A Rojas
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
| | - Ignacio Lorenzo
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
| | | | - Noelia Ania
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
| | - Elena Osácar
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
| | - Ana Sabalza
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
| | - Pilar Amézqueta
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
| | - Begoña López
- CIMA (Center for Applied Medical Research) University of Navarre, Cardiovascular Disease, Pamplona, Spain
| | - Arantxa González
- CIMA (Center for Applied Medical Research) University of Navarre, Cardiovascular Disease, Pamplona, Spain
| | - Javier Diez
- University of Navarra Clinic, Nephrology Department, Pamplona, Spain
- CIMA (Center for Applied Medical Research) University of Navarre, Cardiovascular Disease, Pamplona, Spain
- University of Navarra Clinic, Cardiology Department, Pamplona, Spain
| |
Collapse
|
11
|
Mora-Gutiérrez JM, Soler Romeo MJ, Fernandez-Seara M, Gonzalez Arostegui O, Riera M, Paramo JA, Garcia-Fernandez N. SP452RENAL MMP-10, IS INCREASED IN EARLY DKD IN db/db MODEL AND ANGIOTENSIN RECEPTOR BLOCKADE NORMALIZED ITS EXPRESSION. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz103.sp452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | | | | | | | - Marta Riera
- Institut Hospital del Mar d'Investigacions Mèdiques IMIM, Barcelona, Spain
| | | | | |
Collapse
|
12
|
Lavilla Royo FJ, Alfaro C, Gonzalez O, Rojas M, Lorenzo I, Romero-Gonzalez G, Paloma M, Garcia-Fernandez N. FP317USE OF CORPORAL AND HEMODINAMIC BIOIMPEDANCE IN ACUTE KIDNEY INJURY. PROGNOSIS AND EFFICIENCY IN PATIENT MANAGEMENT. Nephrol Dial Transplant 2019. [DOI: 10.1093/ndt/gfz106.fp317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
13
|
Garcia-Fernandez N, Beaumont J, Moreno MU, San José G, González A, Díez J. The renal immune-inflammatory component of arterial hypertension: emerging therapeutic strategies. Cardiovasc Res 2019; 115:696-698. [PMID: 30407495 DOI: 10.1093/cvr/cvy280] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Affiliation(s)
- Nuria Garcia-Fernandez
- Department of Nephrology, University of Navarra Clinic, University of Navarra, Pamplona, Spain.,IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - Javier Beaumont
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.,Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain.,CIBERCV, Carlos III Institute of Health, Madrid, Spain
| | - María U Moreno
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.,Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain.,CIBERCV, Carlos III Institute of Health, Madrid, Spain
| | - Gorka San José
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.,Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain.,CIBERCV, Carlos III Institute of Health, Madrid, Spain
| | - Arantxa González
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.,Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain.,CIBERCV, Carlos III Institute of Health, Madrid, Spain
| | - Javier Díez
- Department of Nephrology, University of Navarra Clinic, University of Navarra, Pamplona, Spain.,IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.,Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain.,CIBERCV, Carlos III Institute of Health, Madrid, Spain.,Department of Cardiology and Cardiac Surgery, University of Navarra Clinic, University of Navarra, Pamplona, Spain
| |
Collapse
|
14
|
Garcia-Fernandez N, Lavilla J, Martín PL, Romero-González G, González A, López B, Ravassa S, Díez J. Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both? Am J Hypertens 2019; 32:15-17. [PMID: 30325410 DOI: 10.1093/ajh/hpy153] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2018] [Accepted: 10/11/2018] [Indexed: 12/23/2022] Open
Affiliation(s)
- Nuria Garcia-Fernandez
- Department of Nephrology, University of Navarra Clinic, University of Navarra, Pamplon, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - Javier Lavilla
- Department of Nephrology, University of Navarra Clinic, University of Navarra, Pamplon, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - Paloma L Martín
- Department of Nephrology, University of Navarra Clinic, University of Navarra, Pamplon, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - Gregorio Romero-González
- Department of Nephrology, University of Navarra Clinic, University of Navarra, Pamplon, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - Arantxa González
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
- Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain
- CIBERCV, Carlos III Institute of Health, Madrid, Spain
| | - Begoña López
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
- Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain
- CIBERCV, Carlos III Institute of Health, Madrid, Spain
| | - Susana Ravassa
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
- Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain
- CIBERCV, Carlos III Institute of Health, Madrid, Spain
| | - Javier Díez
- Department of Nephrology, University of Navarra Clinic, University of Navarra, Pamplon, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
- Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain
- CIBERCV, Carlos III Institute of Health, Madrid, Spain
- Department of Cardiology and Cardiac Surgery, University of Navarra Clinic, University of Navarra, Pamplon, Spain
| |
Collapse
|
15
|
Selby NM, Blankestijn PJ, Boor P, Combe C, Eckardt KU, Eikefjord E, Garcia-Fernandez N, Golay X, Gordon I, Grenier N, Hockings PD, Jensen JD, Joles JA, Kalra PA, Krämer BK, Mark PB, Mendichovszky IA, Nikolic O, Odudu A, Ong ACM, Ortiz A, Pruijm M, Remuzzi G, Rørvik J, de Seigneux S, Simms RJ, Slatinska J, Summers P, Taal MW, Thoeny HC, Vallée JP, Wolf M, Caroli A, Sourbron S. Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA. Nephrol Dial Transplant 2018; 33:ii4-ii14. [PMID: 30137584 PMCID: PMC6106645 DOI: 10.1093/ndt/gfy152] [Citation(s) in RCA: 81] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2018] [Indexed: 12/13/2022] Open
Abstract
Functional renal magnetic resonance imaging (MRI) has seen a number of recent advances, and techniques are now available that can generate quantitative imaging biomarkers with the potential to improve the management of kidney disease. Such biomarkers are sensitive to changes in renal blood flow, tissue perfusion, oxygenation and microstructure (including inflammation and fibrosis), processes that are important in a range of renal diseases including chronic kidney disease. However, several challenges remain to move these techniques towards clinical adoption, from technical validation through biological and clinical validation, to demonstration of cost-effectiveness and regulatory qualification. To address these challenges, the European Cooperation in Science and Technology Action PARENCHIMA was initiated in early 2017. PARENCHIMA is a multidisciplinary pan-European network with an overarching aim of eliminating the main barriers to the broader evaluation, commercial exploitation and clinical use of renal MRI biomarkers. This position paper lays out PARENCHIMA's vision on key clinical questions that MRI must address to become more widely used in patients with kidney disease, first within research settings and ultimately in clinical practice. We then present a series of practical recommendations to accelerate the study and translation of these techniques.
Collapse
Affiliation(s)
- Nicholas M Selby
- Centre for Kidney Research and Innovation, University of Nottingham, UK
| | - Peter J Blankestijn
- Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Peter Boor
- Institute of Pathology and Department of Nephrology, RWTH University, Aachen, Germany
| | - Christian Combe
- Service de Néphrologie Transplantation Dialyse Aphérèse, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
| | - Kai-Uwe Eckardt
- Department of Nephrology and Medical Intensive Care, Charité—Universitätsmedizin Berlin, Berlin, Germany
| | - Eli Eikefjord
- Department of Health and Functioning, Western Norway University of Applied Sciences, Norway
| | | | - Xavier Golay
- Institute of Neurology, University College London, Queen Square, London, UK
| | - Isky Gordon
- Great Ormond Street Institute of Child Health, University College London, London, UK
| | - Nicolas Grenier
- Service d'Imagerie Diagnostique et Interventionnelle de l'Adulte, Centre Hospitalier Universitaire de Bordeaux Place Amelie Raba-Leon, Bordeaux, France
| | | | - Jens D Jensen
- Departments of Renal and Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
| | - Jaap A Joles
- Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Philip A Kalra
- Department of Renal Medicine, Salford Royal Hospital and Division of Cardiovascular Sciences, University of Manchester, Manchester, UK
| | - Bernhard K Krämer
- Vth Department of Medicine, University Medical Center Mannheim, Medical Faculty Mannheim of the University Heidelberg, Mannheim, Germany
| | - Patrick B Mark
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
| | - Iosif A Mendichovszky
- Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK
| | - Olivera Nikolic
- Faculty of Medicine,University of Novi Sad, Center of Radiology, Clinical Centre of Vojvodina, Serbia
| | - Aghogho Odudu
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
| | - Albert C M Ong
- Academic Nephrology Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, UK
| | - Alberto Ortiz
- Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain
| | - Menno Pruijm
- Service of Nephrology and Hypertension, Department of Medicine, University Hospital of Lausanne (CHUV), Lausanne, Switzerland
| | - Giuseppe Remuzzi
- IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy
| | - Jarle Rørvik
- Department of Clinical Medicine, University of Bergen, Bergen, Norway
- Department of Radiology, Haukeland University Hospital, Bergen, Norway
| | - Sophie de Seigneux
- Service of Nephrology, Department of Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland
| | - Roslyn J Simms
- Academic Nephrology Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, UK
| | - Janka Slatinska
- Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
| | - Paul Summers
- Department of Medical Imaging and Radiation Sciences, Radiology Division, European Institute of Oncology (IEO), Milan, Italy
- QMRI Tech iSrl, Piazza dei Martiri Pennesi 20, Pescara, Italy
| | - Maarten W Taal
- Centre for Kidney Research and Innovation, University of Nottingham, UK
| | - Harriet C Thoeny
- University of Bern, Inselspital, Bern, Switzerland
- HFR Fribourg, Hôpital Cantonal, Fribourg, Switzerland
| | - Jean-Paul Vallée
- Radiology Department, Geneva University Hospital and University of Geneva, Geneva, Switzerland
| | - Marcos Wolf
- Center for Medical Physics and Biomedical Engineering, MR-Centre of Excellence, Medical University of Vienna, Vienna, Austria
| | - Anna Caroli
- IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy
| | - Steven Sourbron
- Leeds Imaging Biomarkers Group, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, UK
| |
Collapse
|
16
|
Maduell F, Garcia-Fernandez N, Manrique J, González A, Díez J. Unraveling New Mechanisms of Renal Fibrosis With Potential Therapeutic Implications. Hypertension 2018; 72:277-278. [PMID: 29915017 DOI: 10.1161/hypertensionaha.118.11043] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Francisco Maduell
- From the Division of Nephrology and Renal Transplantation, Hospital Clínic, University of Barcelona, Spain (F.M.)
| | - Nuria Garcia-Fernandez
- Department of Nephrology (N.G.-F., J.D.).,Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (N.G.-F., J.M., A.G., J.D.)
| | - Joaquín Manrique
- University of Navarra Clinic, Pamplona, Spain; Division of Nephrology, Complejo Hospitalario de Navarra, Pamplona, Spain (J.M.).,Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (N.G.-F., J.M., A.G., J.D.)
| | - Arantxa González
- Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (A.G., J.D.).,Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Carlos III Institute of Health, Madrid, Spain (A.G., J.D.).,Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (N.G.-F., J.M., A.G., J.D.)
| | - Javier Díez
- Department of Nephrology (N.G.-F., J.D.) .,Department of Cardiology and Cardiac Surgery (J.D.).,Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain (A.G., J.D.).,Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Carlos III Institute of Health, Madrid, Spain (A.G., J.D.).,Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (N.G.-F., J.M., A.G., J.D.)
| |
Collapse
|
17
|
Lavilla Royo FJ, Moiron Fernandez Hinojosa P, Alfaro Sanchez CI, Gonzalez Aristegui OJ, Rojas Fernandez MA, Garcia-Fernandez N, Martín PL, Errasti Goenaga P. SP226CARDIOTHORACIC BIOIMPEDANCE AND ACUTE KIDNEY INJURY. THORACIC VOLEMIA AND RENAL REPLACEMENT TREATMENT. VASCULAR RESISTANCE AND PROGNOSIS. Nephrol Dial Transplant 2018. [DOI: 10.1093/ndt/gfy104.sp226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Alfaro CI, Echarri G, Moirón JP, Monedero P, Gonzalez OJ, Calderon R, Lavilla J, Martín PL, Garcia-Fernandez N. SP244IS URINARY NEPHROCHECK TEST USEFUL IN CLINICAL DIAGNOSIS AND THERAPEUTICAL DECISION FOR ACUTE KIDNEY DISEASE IN CRITICALLY ILL PATIENTS? Nephrol Dial Transplant 2018. [DOI: 10.1093/ndt/gfy104.sp244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - Gemma Echarri
- Anesthesia-ICU, University of Navarra, Pamplona, Spain
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Lavilla Royo FJ, Moiron Fernandez Hinojosa P, Alfaro Sanchez CI, Gonzalez Aristegui OJ, Rojas Fernandez MA, Garcia-Fernandez N, Martín PL, Errasti Goenaga P. SP201BIOIMPEDANCE IN ACUTE RENAL FAILURE PROGNOSIS. PHASE ANGLE, NUTRITIONAL AND VOLEMIC PARAMETERS. Nephrol Dial Transplant 2018. [DOI: 10.1093/ndt/gfy104.sp201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
20
|
Mora-Gutierrez JM, Fernandez-Seara MA, Slon Roblero MF, Gonzalez O, Escalada FJ, Soler MJ, Paramo JA, Garcia-Fernandez N. SP453MATRIX METALLOPROTEINASE-10 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) AS EARLY PREDICTORS OF NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Nephrol Dial Transplant 2018. [DOI: 10.1093/ndt/gfy104.sp453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | | | | | | | | | | | - Jose A Paramo
- Atherosclerosis Research Laboratory, Center for Applied Medical Research, University of Navarra, Pamplona, Spain
| | | |
Collapse
|
21
|
Del Pozo J, Aguinaga A, Garcia-Fernandez N, Hernaez S, Serrera A, Alonso M, Ramos A, Guillen-Grima F, Leiva J. Intra-Catheter Leukocyte Culture to Monitor Hemodialysis Catheter Colonization. a Prospective Study to Prevent Catheter-Related Bloodstream Infections. Int J Artif Organs 2018; 31:820-6. [DOI: 10.1177/039139880803100910] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The most serious problem related to the use of tunneled catheters in hemodialysis is bacteremia. The aim of this study was to detect hemodialysis catheter colonization and, establish a preemptive therapy based on a catheter antibiotic lock in order to prevent development of catheter-related bloodstream infections. During a 24-month period, all patients with tunneled catheters in our hemodialysis unit were evaluated by extracting a through-catheter leukocyte culture every 15 days. There were 28 episodes of catheter colonization occurring in 13 patients (2.2 colonization episodes per 1000 catheter patient-days). At the time of colonization, catheters had been in place for a mean of 562 days (range: 16 to 1475 days). Coagulase negative staphylococci (CNS) were the most common microorganisms to be isolated. A preemptive therapy consisting in teicoplanin locks (10 mg/mL) for 21 days was able to eradicate catheter colonization in 89% of the cases when CNS were isolated. However, relapse of colonization occurred in 61.2% of these cases. The mean duration of catheter use was 239 days (range: 9 to 483 days) after treatment of a colonization episode. The incidence of catheter-related bloodstream infection in our population was 0.78 episodes per 1000 catheter patient-days (IC 95%: 0.374–1.434). This study shows the utility of intra-catheter leukocyte culture for early detection of hemodialysis catheter colonization. Moreover, it establishes that the eradication of biofilm-related CNS is possible without the removal of the catheter, thus enabling a longer catheter lifespan. (Int J Artif Organs 2008; 31: 820–6)
Collapse
Affiliation(s)
- J.L. Del Pozo
- Division of Infectious Diseases and Clinical Microbiology, University Clinic of Navarra, Pamplona - Spain
- Department of Microbiology, University Clinic of Navarra, Pamplona - Spain
| | - A. Aguinaga
- Department of Microbiology, University Clinic of Navarra, Pamplona - Spain
| | | | - S. Hernaez
- Department of Microbiology, University Clinic of Navarra, Pamplona - Spain
| | - A. Serrera
- Department of Microbiology, University Clinic of Navarra, Pamplona - Spain
| | - M. Alonso
- Department of Microbiology, University Clinic of Navarra, Pamplona - Spain
| | - A. Ramos
- Department of Microbiology, University Clinic of Navarra, Pamplona - Spain
| | - F. Guillen-Grima
- Department of Preventive Medicine, University Clinic of Navarra, Pamplona - Spain
| | - J. Leiva
- Department of Microbiology, University Clinic of Navarra, Pamplona - Spain
| |
Collapse
|
22
|
Arias Pou P, Aquerreta Gonzalez I, Idoate García A, Garcia-Fernandez N. Improvement of drug prescribing in acute kidney injury with a nephrotoxic drug alert system. Eur J Hosp Pharm 2017; 26:33-38. [PMID: 31157093 DOI: 10.1136/ejhpharm-2017-001300] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2017] [Revised: 08/03/2017] [Accepted: 08/08/2017] [Indexed: 01/29/2023] Open
Abstract
Objective Electronic alert systems have shown their capacity for improving the detection of acute kidney injury (AKI). The aim of this study was to design and implement a clinical decision support system (CDSS) for improving drug selection and reducing nephrotoxic drug use in patients with AKI. Methods The study was designed as an intervention study comparing a pre and post cohort of patients admitted during April 2014 and April 2015, respectively (phase I and phase II). The intervention was a CDSS which provided kidney function and nephrotoxic drug information. Furthermore, an interruptive alert was designed to detect patients suffering an AKI event while taking a nephrotoxic drug and to see if the dose was then reduced or the drug was discontinued by the physicians. Results One-third of the inpatients were included in the analysis because they met the inclusion criteria (1004 and 1002 patients in phases I and II, respectively). 735 and 761 of them received at least one nephrotoxic alert (73% vs 76%; p=0.763). 65 and 88 patients suffered AKI during admission (6.5% vs 8.8%; p=0.051). In phase I, patients received 384 nephrotoxic alerts (55%) with 78 (20%) of them provoking a change or discontinuation of the nephrotoxic drug. In phase II this value increased to 154 out of 526 (29%) after implementation of the CDSS (p<0.01). Conclusions A CDSS with interruptive alerts that inform of the development of AKI in real time in patients with nephrotoxic drug prescription has a positive impact on the judicious use of these drugs.
Collapse
Affiliation(s)
- Paloma Arias Pou
- Hospital Pharmacy, Clínica Universidad de Navarra, Madrid, Spain
| | | | | | | |
Collapse
|
23
|
Mora-Gutierrez JM, Fernandez-Seara MA, Slon F, Wang DJJ, Paramo JA, Escalada J, Garcia-Fernandez N. SO002ARTERIAL SPIN LABELING MAGNETIC RESONANCE IMAGING (ASL-MRI) AND RENAL PERFUSION DATA IN DIABETIC PATIENTS. Nephrol Dial Transplant 2017. [DOI: 10.1093/ndt/gfx099.so002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
24
|
Lavilla Royo FJ, Gonzalez Aristegui OJ, Molina Higueras MJ, Alfaro Sanchez CI, Moiron Fernandez Hinojosa P, Bello Ovalles AE, Garcia-Fernandez N, Mora Gutierrez JM, Errasti Goenaga P. MP127CARDIOVASCULAR RISK IN HEALTHY SUBJECTS EVALUATED WITH CARDIOVASCULAR AGE, RENAL FUNCTION AND CAROTID ECHOGRAPHY. Nephrol Dial Transplant 2017. [DOI: 10.1093/ndt/gfx163.mp127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Lavilla Royo FJ, Alfaro Sanchez CI, Gonzalez Aristegui OJ, Molina Higueras MJ, Moiron Fernandez Hinojosa P, Bello Ovalles AE, Martín PL, Garcia-Fernandez N, Errasti Goenaga P. SP216GERIATRIC NEPHROLOGY. ACUTE KIDNEY INJURY IN ELDERLY PATIENT. DIFFERENCES IN ETIOLOGY, MORBIDITY AND MORTALITY. AGE IS NOT A PROGNOSTIC FACTOR. Nephrol Dial Transplant 2017. [DOI: 10.1093/ndt/gfx143.sp216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Lavilla Royo FJ, Moiron Fernandez Hinojosa P, Alfaro Sanchez CI, Gonzalez Aristegui OJ, Molina Higueras MJ, Garcia-Fernandez N, Bello Ovalles AE, Errasti Goenaga P. MP287EXTRACELULAR CORPORAL AND CARDIOTHORACIC HYPERVOLEMIA, AS A PROGNOSTIC MARKERS IN ACUTE KIDNEY INJURY. Nephrol Dial Transplant 2017. [DOI: 10.1093/ndt/gfx167.mp287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Moiron JP, Izaguirre M, Alfaro CI, González OJ, Monedero P, Calderon R, Varo N, Lavilla J, Bello E, Errasti P, Garcia-Fernandez N. SP200URINARY TISSUE INHIBITOR METALLOPROTEINASE-2 AND IGF-BINDING PROTEIN-7 LEVELS ARE ASSOCIATED WITH PERSISTENT OLIGURIA AND LONGER REQUIREMENT FOR REPLACEMENT THERAPY. Nephrol Dial Transplant 2017. [DOI: 10.1093/ndt/gfx143.sp200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
28
|
Mora-Gutiérrez JM, Garcia-Fernandez N, Slon Roblero MF, Páramo JA, Escalada FJ, Wang DJ, Benito A, Fernández-Seara MA. Arterial spin labeling MRI is able to detect early hemodynamic changes in diabetic nephropathy. J Magn Reson Imaging 2017; 46:1810-1817. [PMID: 28383796 DOI: 10.1002/jmri.25717] [Citation(s) in RCA: 57] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2017] [Accepted: 03/15/2017] [Indexed: 11/06/2022] Open
Abstract
PURPOSE To investigate whether arterial spin labeling (ASL) MRI could detect renal hemodynamic impairment in diabetes mellitus (DM) along different stages of chronic kidney disease (CKD). MATERIALS AND METHODS Three Tesla (3T) ASL-MRI was performed to evaluate renal blood flow (RBF) in 91 subjects (46 healthy volunteers and 45 type 2 diabetic patients). Patients were classified according to their estimated glomerular filtration rate (eGFR) as group I (eGFR > 60 mL/min/1.73 m2 ), group II (60 ≥ eGFR>30 mL/min/1.73 m2 ), or group III (eGFR ≤ 30 mL/min/1.73 m2 ), to determine differences depending on renal function. Studies were performed at 3T using a 12-channel flexible body array combined with the spine array coil as receiver. RESULTS A 28% reduction in cortical RBF was seen in diabetics in comparison with healthy controls (185.79 [54.60] versus 258.83 [37.96] mL/min/100 g, P < 3 × 10-6 ). Differences were also seen between controls and diabetic patients despite normal eGFR and absence of overt albuminuria (RBF [mL/min/100 g]: controls=258.83 [37.96], group I=208.89 [58.83], P = 0.0018; eGFR [mL/min/1.73 m2 ]: controls = 95.50 [12.60], group I = 82.00 [20.76], P > 0.05; albumin-creatinine ratio [mg/g]: controls = 3.50 [4.45], group I = 17.50 [21.20], P > 0.05). A marked decrease in RBF was noted a long with progression of diabetic nephropathy (DN) through the five stages of CKD (χ2 = 43.58; P = 1.85 × 10-9 ). Strong correlation (r = 0.62; P = 4 × 10-10 ) was obtained between RBF and GFR estimated by cystatin C. CONCLUSION ASL-MRI is able to quantify early renal perfusion impairment in DM, as well as changes according to different CKD stages of DN. In addition, we demonstrated a correlation of RBF quantified by ASL and GFR estimated by cystatin C. LEVEL OF EVIDENCE 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2017;46:1810-1817.
Collapse
Affiliation(s)
| | | | | | - Jose A Páramo
- Atherosclerosis Research Laboratory, CIMA, University of Navarra, Pamplona, Spain
| | | | - Danny Jj Wang
- Laboratory of Functional MRI Technology (LOFT) Stevens Neuroimaging and Informatics Institute University of Southern California, Los Angeles, California, USA
| | | | - María A Fernández-Seara
- Radiology, Clínica Universidad de Navarra, Spain.,Adjunct Associate Professor of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
29
|
Garcia-Fernandez N, Hassan A, Anand S. 0552 Evaluation of microbial enzymes for degradation of exopolymeric substances (EPS) within biofilm matrices for more effective cleaning. J Anim Sci 2016. [DOI: 10.2527/jam2016-0552] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
30
|
Alfaro C, Molina MJ, Moiron Fernandez-Felechosa JP, Mora JM, Martin-Moreno PL, Lavilla Royo J, Errasti P, Garcia-Fernandez N. SP417EFFICACY AND SAFETY OF BEMIPARINE AS ANTICOAGULANT IN BOTH HEMODIALYSIS AND ON-LINE HEMODIAFILTRATION (OL-HDF): A PROPOSAL OF DOSE RECOMMENDATION. Nephrol Dial Transplant 2016. [DOI: 10.1093/ndt/gfw170.24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
31
|
Chacon A, Soler MJ, Escalada J, Riera M, Mora JM, Garcia-Fernandez N. MP429LEVELS OF SERUM ANGIOTENSIN-CONVERTING ENZYME TYPE 2 (ACE2) ARE ASSOCIATED WITH INCREASED INSULIN RESISTANCE INDEPENDENTLY OF ALBUMINURIA IN TYPE 2 DIABETES. Nephrol Dial Transplant 2016. [DOI: 10.1093/ndt/gfw193.03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
32
|
Moiron Fernandez-Felechosa JP, López Espinosa D, Izaguirre M, Molina Higueras MJ, Mora Gutierrez JM, Martín Moreno PL, Lavilla Royo FJ, Calderon R, Monedero P, Varo N, Garcia-Fernandez N. MP201URINARY TISSUE INHIBITOR METALLOPROTEINASE-2 (TIMP-2) AND IGF-BINDING PROTEIN-7 (IGFBP7) LEVELS ARE ASSOCIATED WITH PERSISTENT OLIGURIA IN ACUTE KIDNEY INJURY: PRELIMINARY RESULTS. Nephrol Dial Transplant 2016. [DOI: 10.1093/ndt/gfw187.07] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Mora-Gutierrez JM, Garcia-Fernandez N, Molina MJ, Wang D, Benito A, Slon MF, Paramo JA, Fernandez-Seara MA. SP383ASSESSMENT OF RENAL PERFUSION IN TYPE 2 DIABETES MELLITUS USING ARTERIAL SPIN LABELING MAGNETICRESONANCE IMAGING. Nephrol Dial Transplant 2016. [DOI: 10.1093/ndt/gfw169.05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
34
|
Martin-Moreno PL, Varo N, Martínez-Ansó E, Martin-Calvo N, Sayón-Orea C, Bilbao JI, Garcia-Fernandez N. Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial. Nephron Clin Pract 2015; 131:51-8. [PMID: 26336919 DOI: 10.1159/000438907] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2015] [Accepted: 07/21/2015] [Indexed: 11/19/2022] Open
Abstract
AIMS Contrast-induced acute kidney injury (CI-AKI) is a common cause of renal failure. We evaluated the effectiveness of oral sodium citrate versus intravenous (IV) sodium bicarbonate for CI-AKI prophylaxis as well as their influence on kidney injury biomarkers. MATERIAL AND METHODS A randomized, controlled, single-center study including 130 hospitalized patients (62.3% men), who were randomized to receive sodium bicarbonate (1/6 men, 3 ml/kg/h for 1 h; n = 43), oral sodium citrate (75 ml/10 kg divided into 4 doses; n = 43) or nonspecific hydration (n = 44) before contrast administration, was conducted. Serum creatinine and kidney injury biomarkers (cystatin C, neutrophil gelatinase-associated lipocalin, interleukin-8, F2-isoprostanes and cardiotrophin-1 [CT-1]) were assessed. RESULTS Incidence of CI-AKI was 9.2% with no differences found between hydration groups: 7.0% in sodium bicarbonate group, 11.6% in oral sodium citrate group and 9.1% in the nonspecific hydration group. Urinary creatinine and urinary CT-1/creatinine ratio decreased 4 h after contrast infusion (p < 0.001), but none of the biomarkers assessed were affected by the treatments. CONCLUSIONS There were no differences in hydration with oral sodium citrate and IV sodium bicarbonate for the prophylaxis of CI-AKI. Therefore, oral hydration represents a safe, inexpensive and practical method for preventing CI-AKI in low-risk patients. No effect on biomarkers for kidney injury could be demonstrated.
Collapse
|
35
|
Lavilla Royo FJ, Nuñez Cordoba J, Molina MJ, Mora Gutierrez JM, Lopez Espinosa D, Moiron P, Garcia-Fernandez N, Martín PL, Errasti Goenaga P. SP264ASSOCIATION BETWEEN PHASE ANGLE AND MORTALITY RISK IN ACUTE KIDNEY INJURY PATIENTS. Nephrol Dial Transplant 2015. [DOI: 10.1093/ndt/gfv190.76] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Lavilla Royo FJ, Posadas Pita GJ, Molina MJ, Garcia-Fernandez N, Mora Gutierrez JM, Lopez Espinosa D, Moiron P, Martín PL, Errasti Goenaga P. SP199HYPERVOLEMIA AND ACUTE KIDNEY INJURY. EXTRACELULAR/INTRACELULAR RATIO AND PROGNOSIS. BIOIMPEDANCE ANALYSIS APLICATION TO PREVENT HYPEREXPANSION. Nephrol Dial Transplant 2015. [DOI: 10.1093/ndt/gfv190.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
37
|
Kutlay S, Kurultak I, Nergizoglu G, Erturk S, Karatan O, Azevedo P, Pinto CT, Pereira CM, Marinho A, Vanmassenhove J, Hoste E, Glorieux G, Dhondt A, Vanholder R, Van Biesen W, Rei S, Aleksandrova I, Kiselev V, Ilynskiy M, Berdnikov G, Marchenkova L, Vanmassenhove J, Hoste E, Glorieux G, Dhondt A, Vanholder R, Van Biesen W, Daher EF, Vieira APF, Souza JB, Falcao FS, Costa CR, Fernandes AACS, Mota RMS, Lima RSA, Silva Junior GB, Ulusal Okyay G, Erten Y, Er R, Aybar M, Inal S, Tekbudak M, Aygencel G, Onec K, Bali M, Sindel S, Soto K, Fidalgo P, Papoila AL, Vanmassenhove J, Hoste E, Glorieux G, Dhondt A, Vanholder R, Van Biesen W, Lentini P, Zanoli L, Granata A, Contestabile A, Basso A, Berlingo G, de Cal M, Pellanda V, Dell'Aquila R, Fortrie G, Stads S, van Bommel J, Zietse R, Betjes MG, Berrada A, Arias C, Riera M, Orfila MA, Rodriguez E, Barrios C, Peruzzi L, Chiale F, Camilla R, Martano C, Cresi F, Bertino E, Coppo R, Klimenko A, Villevalde S, Efremovtseva M, Kobalava Z, Pipili C, Ioannidou S, Kokkoris S, Poulaki S, Tripodaki ES, Parisi M, Papastylianou A, Nanas S, Wang YN, Cheng H, Chen YP, Wen Z, Li X, Shen P, Zou Y, Lu Y, Ma X, Chen Y, Ren H, Chen X, Chen N, Yue T, Cheng H, Chen YP, Elmamoun S, Wodeyar H, Goldsmith C, Abraham A, Wootton A, Ahmed S, Hill C, Curtis S, Miller A, Hine T, Stevens KK, Patel RK, Mark PB, Delles C, Jardine AG, Wilflingseder J, Heinzel A, Mayer P, Perco P, Kainz A, Mayer B, Oberbauer R, Huang TM, Wu VC, Park DJ, Bae EJ, Kang YJ, Cho HS, Chang SH, Lentini P, Zanoli L, Granata A, Contestabile A, Berlingo G, Basso A, Pellanda V, de Cal M, Stramana R, Cognolato D, Baiocchi M, Dell'Aquila R, Chiella BM, Pilla C, Balbinotto A, Antunes VH, Heglert A, Collares FM, Thome FS, Gjyzari A, Thereska N, Xhango O, Xue J, Chen MC, Wang L, Chen YJ, Sun XZ, An WS, Kim ES, Son YK, Kim SE, Kim KH, Oh YJ, Tsai HB, Ko WJ, Chao CT, Fortrie G, Stads S, Aarnoudse AJL, Zietse R, Betjes MG, Peride I, Radulescu D, Niculae A, Ciocalteu A, Checherita AI, Kao CC, Wang CY, Lai CF, Huang TM, Chen HH, Wu VC, Ko WJ, Wu KD, Klaus F, Goldani JC, Cantisani G, Zanotelli ML, Carvalho L, Klaus D, Garcia VD, Keitel E, Hussaini SM, Rao PN, Kul A, Ye N, Zhang Y, Cheng H, Chen YP, Baines R, Westacott R, Trew J, Kirtley J, Selby N, Carr S, Xu G, Steffgen J, Blaschke S, Brun-Schulte-Wissing N, Pagel P, Huber F, Mapes J, Jaehnige A, Pestel S, Deray G, Rouviere O, Bacigalupo L, Maes B, Hannedouche T, Vrtovsnik F, Rigothier C, Billiouw JM, Campioni P, Marti-Bonmati L, Gao YM, Li D, Cheng H, Chen YP, Woo S, Lee J, Noh H, Kwon SH, Han DC, Hetherington L, Valluri A, McQuarrie E, Fleming S, Geddes C, Bell S, MacKinnon B, Bell S, Patton A, Sneddon J, Donnan P, Vadiveloo T, Marwick C, Bennie M, Davey P, Yasuda H, Tsuji N, Tsuji T, Iwakura T, Ohashi N, Kato A, Fujigaki Y, Sasaki S, Kawarazaki H, Shibagaki Y, Kimura K, Lingaraju U, Rajanna S, Radhakrishnan H, Parekh A, Sreedhar CG, Sarvi R, Rainone F, Merlino L, Ritchie JP, Kalra PA, Daher EF, Vieira APF, Jacinto CN, Abreu KLS, Silva Junior GB, Neves M, Baptista JP, Rodrigues L, Pinho J, Teixeira L, Pimentel J, Gonzalez Sanchidrian S, Rangel Hidalgo G, Cebrian Andrada C, Deira Lorenzo J, Marin Alvarez J, Garcia-Bernalt Funes V, Gallego Dominguez S, Labrador Gomez P, Castellano Cervino I, Novillo Santana R, Gomez-Martino Arroyo J, Kim Y, Choi BS, Kim YO, Yoon SA, Lin MC, Wu VC, Ko WJ, Wu KD, Wang WJ, Melo MJ, Lopes JA, Raimundo M, Fragoso A, Antunes F, Martin-Moreno PL, Varo N, Restituto P, Sayon-Orea C, Garcia-Fernandez N, Leite Filho NCV, Souza LEO, Cavalcante RM, Silva Junior GB, Morais BM, Leite TT, Silva SL, Kubrusly M, Daher EF, Jung YS, Kim YN, Shin HS, Rim H, Bentall A, Al-Baaj F, Williamson S, Cheshire S, Jelakovic M, Ivkovic V, Laganovic M, Karanovic S, Pecin I, Premuzic V, Vukovic Lela I, Vrdoljak A, Fucek M, Cvitkovic A, Juric D, Bozina N, Bitunjac M, Leko N, Abramovic Baric M, Matijevic V, Jelakovic B, Ullah A, Exarchou K, Archer T, Anijeet H, Brown R, Ahmed S, Zhang Y, Ye N, Cheng H, Cheng YP, Rocha JCG, Gushiken da Silva T, de Castro PF, Kioroglo PS, Branco Martins JP, Tzanno-Martins C, Biesenbach P, Luf F, Fleischmann E, Grunberger T, Druml W, Gaipov A, Turkmen K, Toker A, Solak Y, Cicekler H, Ucar R, Kilicaslan A, Gormus N, Tonbul HZ, Yeksan M, Turk S, Monteburini T, Cenerelli S, Santarelli S, Boggi R, Tazza L, Bossola M, Ferraresi M, Merlo I, Giovinazzo G, Quercia AD, Gai M, Leonardi G, Anania P, Guarena C, Cantaluppi V, Pacitti A, Biancone L, Hissa PNG, Daher EDF, Liborio AB, Thereza BMF, Mendes CCP, Sousa ARO. AKI - human studies. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft129] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Power A, Duncan N, Pusey C, Usvyat L, Marcelli D, Marelli C, Kotanko P, Li Z, Wang J, Yuan X, Wang J, Wang L, Ozkayar N, Altun B, Yildirim T, Yilmaz R, Dede F, Hayran M, Arici M, Aki T, Erdem Y, Vink EE, Siddiqi L, Verloop WL, van Schelven LJ, Liam Oey P, Blankestijn PJ, Vink EE, Verloop WL, Voslkuil M, Spiering W, Vonken EJ, Blankestijn PJ, Branco PQ, Gaspar AC, Sousa HS, Martins AR, Dores H, Goncalves P, Almeida M, Mendes M, Barata JD, Shi X, Xia P, Wen Y, Jiang L, Li H, Li X, Li X, Chen L, Quiroz YJ, Franco M, Tapia E, Bautista R, Pacheco U, Santamaria J, Johnson RJ, Rodriguez-Iturbe B, Suttorp MM, Hoekstra T, Dekker FW, Lin L, Zhang W, Yang J, He Y, Maciorkowska D, Zbroch E, Koc-Zorawska E, Malyszko JS, Mysliwiec MC, Malyszko J, Sala N, Navarro Diaz M, Serra A, Lopez D, Bonet J, Romero R, Qiu L, Li Y, Chen L, Zhu G, Schiller A, Bob F, Enache A, Jurca-Simina F, Mociar D, Bozdog G, Munteanu M, Petrica L, Velciov S, Bansal V, Timar R, Branco PQ, Gaspar AC, Sousa HS, Martins AR, Goncalves PA, Dores H, Mendes A, Mendes M, Barata JD, Calderon C, Lavilla FJ, Mora JM, Lopez D, Garcia-Fernandez N, Martin PL, Errasti P, David C, Ciocalteu A, Niculae A, Checherita AI, Otowa T, Yasuda T, Uehara K, Kawarazaki H, Shibagaki Y, Kimura K, Hasegawa H, Kanozawa K, Asakura J, Takayanagi K, Tayama Y, Okazaki S, Hara H, Kiba T, Mitani T, Iwanaga M, Ogawa T, Matsuda A, Mitarai T, Yilmaz Z, Yildirim T, Yilmaz R, Aybal-Kutlugun A, Altun B, Kucukozkan T, Erdem Y, Abbss SR, Zhu F, Flores-Gama C, Williams C, Podesta MA, Cartagena C, Carter M, Levin NW, Kotanko P, Gerasimovska Kitanovska B, Bogdanovska S, Severova Andreevska G, Gerasimovska V, Sikole A, Zafirovska K, Boubaker K, Kheder A, Kaaroud H, Lee SM, Park HE, Kim M, Heo NJ, Choi SY, Joo KW, Han JS, Shah S, Pandya B, Schiller A, Munteanu M, Enache A, Bob F, Jurca-Simina F, Mociar D, Timar R, Karanovic S, Fistrek Prlic M, Kos J, Premuzic V, Abramovic Baric M, Matijevic V, Fucek M, Vrdoljak A, Cvitkovic A, Leko N, Bitunjac M, Laganovic M, Jelakovic B, Antlanger M, Kovarik JJ, Domenig O, Kaltenecker C, Hecking M, Haidinger M, Werzowa J, Kopecky C, Heinzl H, Poglitsch M, Saemann MD, Bartmanska M, Wyskida K, Baba M, Tarski M, Adamczak M, Wiecek A, Szotowska M, Fistrek Prlic M, Karanovic S, Pecin I, Laganovic M, Vedran P, Vrdoljak A, Fucek M, Cvitkovic A, Bitunjac M, Abramovic Baric M, Matijevic V, Jelakovic B, Margulis F, Golglid V, Castro C, Ramallo S, Martinez M, Schiavelli R, Demikhova N, Prikhodko O, Vazquez Jimenez LC, Bancu IE, Troya Saborido MI, Bonet Sol J, Tasdemir M, Canpolat N, Caliskan S, Pehlivan G, Sever L, Sasaki K, Kimura T, Sakai S, Iwahashi E, Fujimoto T, Minami S, Oka T, Yokoyama K. Hypertension - human studies. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Locsey L, Seres I, Sztanek F, Harangi M, Padra J, Asztalos L, Paragh G, Hutchison CA, Bevins A, Langham R, Mancini E, Wirta O, Cockwell P, Hutchison CA, Keir R, Vigano M, Stella A, Evans N, Chappell M, Cockwell P, Fabbrini P, Onuigbo M, Onuigbo N, Onuigbo M, Kim S, Chang JH, Jung JY, Lee HH, Chung W, Zanoli L, Rastelli S, Marcantoni C, Tamburino C, Castellino P, Cho A, Choi H, Lee JE, Jang HR, Huh W, Kim YG, Kim DJ, Oh HY, Zanoli L, Rastelli S, Marcantoni C, Tamburino C, Castellino P, Garcia-Fernandez N, Martin-Moreno PL, Varo N, Nunez-Cordoba JM, Schlieper G, Kruger T, Kelm M, Floege J, Westenfeld R, Choi H, Cho AJ, Jang HR, Lee JE, Huh W, Kim YG, Oh HY, Kim DJ, Doganay S, Oguz AK, Ergun I, Bardachenko N, Kuryata O, Bardachenko L, Garcia-Fernandez N, Martin-Moreno PL, Varo N, Nunez-Cordoba JM, Choi H, Cho AJ, Jang HR, Lee JE, Huh W, Kim YG, Oh HY, Kim DJ, Ravani P, Malberti F, Pirelli S, Scolari F, Barrett B, Presta P, Lucisano G, Rubino A, Serraino F, Amoruso T, Renzulli A, Fuiano G, Kielstein JT, Tolk S, Heiden A, Kuhn C, Hoeper MM, Lorenzen J, Broll M, Kaever V, Burhenne H, Hafer C, Haller H, Burkhardt O, Kielstein J, Zahalkova J, Petejova N, Strojil J, Urbanek K, Bertoli S, Musetti C, Cabiati A, Assanelli E, Lauri G, Marana I, De Metrio M, Rubino M, Campodonico J, Grazi M, Moltrasio M, Marenzi G, Unarokov Z, Mukhoedova T, Fidalgo P, Coelho S, Rodrigues B, Fernandes AP, Papoila AL, Liano F, Soto K, Vanmassenhove J, Vanholder R, Glorieux G, Van Biesen W, Challiner R, Ritchie J, Hutchison A, Challiner R, Ritchie J, Hutchison A, Challiner R, Ritchie J, Hutchison A, Zaharie SI, Maria DT, Zaharie M, Vaduva C, Grauntanu C, Cana-Ruiu D, Mota E, Hayer M, Baharani J, Thomas M, Eldehni T, Selby N, McIntyre C, Fluck R, Kolhe N, Fagugli RM, Patera F, Shah PR, Kaswan KK, Kute VB, Vanikar AV, Gumber MR, Patel HV, Munjappa BC, Enginner DP, Sainaresh VV, Trivedi HL, Teixeira C, Nogueira E, Lopes JA, Almeida E, Pais de Lacerda A, Gomes da Costa A, Franca C, Mariano F, Morselli M, Bergamo D, Hollo' Z, Scella S, Maio M, Tetta C, Dellavalle A, Stella M, Triolo G, Cantaluppi V, Quercia AD, Bertinetto P, Giacalone S, Tamagnone M, Basso E, Karvela E, Gai M, Leonardi G, Anania P, Guarena C, Fenocchio CM, Pacitti A, Segoloni GP, Kim YO, Kim HG, Kim BS, Song HCS, Min JK, Kim SY, Park WD, Dalboni M, Narciso R, Quinto M, Grabulosa C, Cruz E, Monte J, Durao M, Cendoroglo M, Santos O, Batista M, Cho A, Choi H, Lee JE, Jang HR, Huh W, Kim YG, Kim DJ, Oh HY, Mancini E, Bellasi A, Giannone S, Mordenti A, Zanoni A, Santoro A, Presta P, Lucisano G, Rubino A, Serraino F, Renzulli A, Fuiano G, Lee JH, Ha SH, Kim JH, Lee GJ, Jung YC, Malindretos P, Koutroumbas G, Patrinou A, Zagkotsis G, Makri P, Togousidis I, Syrganis C, Li Cavoli G, Tortorici C, Bono L, Ferrantelli A, Giammarresi C, Zagarrigo C, Rotolo U, Kim H, Jun K, Choi W, Kim H, Jun K, Choi W, Krzesinski JM, Parotte MC, Vandevelde C, Keenan J, Dieterle F, Sultana S, Pinches M, Ciorciaro C, Schindler R, Schmitz V, Gautier JC, Benain X, Matchem J, Murray P, Adler S, Haase M, Haase-Fielitz A, Devarajan P, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray PT, Zappitelli M, Goldstein S, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler A, Mertens PR, Lacquaniti A, Buemi A, Donato V, Lucisano S, Buemi M, Vanmassenhove J, Vanholder R, Glorieux G, Van Biesen W, Panagoutsos S, Kriki P, Mourvati E, Tziakas D, Chalikias G, Stakos D, Apostolakis S, Tsigalou C, Gioka T, Konstantinides S, Vargemezis V, Torregrosa I, Montoliu C, Urios A, Aguado C, Puchades MJ, Solis MA, Juan I, Sanjuan R, Blasco M, Pineda J, Carratala A, Ramos C, Miguel A, Niculae A, Checherita IA, Sandulovici R, David C, Ciocalteu A, Espinoza M, Hidalgo J, Lorca E, Santibanez A, Arancibia F, Gonzalez F, Park MY, Kim EJ, Choi SJ, Kim JK, Hwang SD, Lee KH, Seok SJ, Yang JO, Lee EY, Hong SY, Gil HW, Astapenko E, Shutov A, Savinova G, Rechnik V, Melo MJ, Lopes JA, Raimundo M, Viegas A, Camara I, Antunes F, Kim MJ, Kwon SH, Lee SW, Song JH, Lee JW. Acute kidney injury - Human studies. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Claure-Del Granado R, Macedo E, Soroko S, Kim YW, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL, Martin-Moreno PL, Garcia-Fernandez N, Varo N, Nunez-Cordoba JM, Haase-Fielitz A, Mertens PR, Plass M, Kuppe H, Hetzer R, Westerman M, Prowle JR, Bellomo R, Haase M, Bolignano D, Zanoli L, Rastelli S, Marcantoni C, Coppolino G, Lucisano G, Tamburino C, Battaglia E, Castellino P. Acute kidney injury / Nephrocalcinosis. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
41
|
Garcia-Fernandez N, Echeverria A, Sanchez-Ibarrola A, Páramo JA, Coma-Canella I. Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis. Nephrology (Carlton) 2010; 15:178-83. [PMID: 20470276 DOI: 10.1111/j.1440-1797.2009.01174.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
AIM Haemodialysis induces endothelial dysfunction by oxidation and inflammation. Intravenous iron administration during haemodialysis could worsen endothelial dysfunction. The aim of this study was to ascertain if iron produces endothelial dysfunction and the possible neutralizing effect of N-acetylcysteine when infused before iron. The oxidative and inflammatory effects of iron during haemodialysis were also assessed. METHODS Forty patients undergoing haemodialysis were studied in a randomized and cross-over design with and without N-acetylcysteine infused before iron sucrose (50 or 100 mg). Plasma Von Willebrand factor (vWF), soluble intercellular adhesion molecule-1 (sICAM-1) levels, malondialdehyde, total antioxidant capacity, CD11b/CD18 expression in monocytes, interleukin (IL)-8 in monocytes and plasma IL-8 were studied at baseline and during haemodialysis. RESULTS Haemodialysis produced significant (P < 0.001) increase in plasma vWF, sICAM-1, malondialdehyde, IL-8 and CD11b/CD18 expression in monocytes, as well as decrease in total antioxidant capacity. Iron induced significant increase in plasma malondialdehyde and IL-8 in monocytes, but had no effect on total antioxidant capacity, CD11b/CD18 expression, plasma IL-8, vWF and sICAM-1. The addition of N-acetylcysteine to 50 mg of iron produced a significant (P = 0.040) decrease in malondialdehyde. CONCLUSION Standard (100 mg) and low (50 mg) doses of iron during haemodialysis had no effects on endothelium. Iron only had minor effects on inflammation and produced an increase in oxidative stress, which was neutralized by N-acetylcysteine at low iron dose. Haemodialysis caused a significant increase in oxidative stress, inflammation and endothelial dysfunction markers.
Collapse
|
42
|
Perez-Valdivieso JR, Monedero P, Vives M, Garcia-Fernandez N, Bes-Rastrollo M. Cardiac-surgery associated acute kidney injury requiring renal replacement therapy. A Spanish retrospective case-cohort study. BMC Nephrol 2009; 10:27. [PMID: 19772621 PMCID: PMC2759914 DOI: 10.1186/1471-2369-10-27] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2009] [Accepted: 09/22/2009] [Indexed: 12/29/2022] Open
Abstract
Background Acute kidney injury is among the most serious complications after cardiac surgery and is associated with an impaired outcome. Multiple factors may concur in the development of this disease. Moreover, severe renal failure requiring renal replacement therapy (RRT) presents a high mortality rate. Consequently, we studied a Spanish cohort of patients to assess the risk factors for RRT in cardiac surgery-associated acute kidney injury (CSA-AKI). Methods A retrospective case-cohort study in 24 Spanish hospitals. All cases of RRT after cardiac surgery in 2007 were matched in a crude ratio of 1:4 consecutive patients based on age, sex, treated in the same year, at the same hospital and by the same group of surgeons. Results We analyzed the data from 864 patients enrolled in 2007. In multivariate analysis, severe acute kidney injury requiring postoperative RRT was significantly associated with the following variables: lower glomerular filtration rates, less basal haemoglobin, lower left ventricular ejection fraction, diabetes, prior diuretic treatment, urgent surgery, longer aortic cross clamp times, intraoperative administration of aprotinin, and increased number of packed red blood cells (PRBC) transfused. When we conducted a propensity analysis using best-matched of 137 available pairs of patients, prior diuretic treatment, longer aortic cross clamp times and number of PRBC transfused were significantly associated with CSA-AKI. Patients requiring RRT needed longer hospital stays, and suffered higher mortality rates. Conclusion Cardiac-surgery associated acute kidney injury requiring RRT is associated with worse outcomes. For this reason, modifiable risk factors should be optimised and higher risk patients for acute kidney injury should be identified before undertaking cardiac surgery.
Collapse
Affiliation(s)
- Jose Ramon Perez-Valdivieso
- Department of Anesthesia and Critical Care, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.
| | | | | | | | | | | |
Collapse
|
43
|
Lavilla J, Perez-Gracia JL, Gurpide A, Garcia-Fernandez N, Lopez-Picazo JM, Pujante D, Chopitea A, Hernandez AP, Garcia-Foncillas J, Martin-Algarra S. Prospective analysis of prognosis in oncology patients with acute renal failure according to different organ failures. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.8150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- J. Lavilla
- Univ Hospital, Univ of Navarra, Pamplona, Navarra, Spain
| | | | - A. Gurpide
- Univ Hospital, Univ of Navarra, Pamplona, Navarra, Spain
| | | | | | - D. Pujante
- Univ Hospital, Univ of Navarra, Pamplona, Navarra, Spain
| | - A. Chopitea
- Univ Hospital, Univ of Navarra, Pamplona, Navarra, Spain
| | | | | | | |
Collapse
|
44
|
Garcia-Fernandez N, Tantengco VO. Urinary riboflavin excretion in normal Filipino non-pregnant, pregnant and lactating women. Southeast Asian J Trop Med Public Health 1974; 5:439-46. [PMID: 4432103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|